ArticleTherapeutic advances in medical oncology2025

Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis.

Linjing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.